drugset
drugset / Trial / NCT00653120

Bioavailability Study of Propranolol Under Fasting Conditions

NCT00653120 ↗

Phase 2 Completed 48 enrolled Par Pharmaceutical, Inc. SFBC Anapharm · collab
RandomizedCrossoverOpen-label

Summary

To compare the single-dose bioavailability of Propranolol 160 Mg ER capsules with Inderal-La

Timeline

Start
2005-05
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 160 mg —

Indications

No indication recorded.